Hints and tips:
...Boston Scientific and Edwards Lifesciences, both of which have large cardiovascular businesses, command an average multiple of around 22....
...(FT) Nervous new era for Hong Kong Inc The chance arrest of Liu Chung-yin, a 30-year-old pilot with Hong Kong airline Cathay Pacific Airways, has plunged his employer into the biggest political crisis since...
...Many Indian entrepreneurs have been slowing organic expansion at home and boosting foreign buyouts, such as UPL Corp’s takeover of US-based Arysta LifeScience....
...Genus, the farmyard geneticist, was down 3.7 per cent to £37.71. Cantor Fitzgerald started coverage of Genus with “hold” advice, saying a valuation of 23 times 2016 earnings looked fair....
...The Aim-listed stock fell 13 per cent on Monday after the company ended an agreement with Arysta LifeScience to develop and sell treatments in the US combining PHC’s protein technology for improving crop...
...Edwards Lifesciences Corp rose 1.87 per cent to close at $145.12. Genworth Financial and Western Digital Corp shed last week’s gains, falling 3.36 per cent to $7.48 and 1.30 per cent to $79.82....
...Backed by Bill Ackman’s Pershing Square hedge fund, Platform Speciality has in the past year added to its portfolio Arysta LifeSciences for $5.4bn, and OM Group for $365m....
...Using the term “cannabis”, the scientific name for the plant genus, is part of that evolution too, he says, because it doesn’t have the negative connotations of “marijuana” or “weed”....
...Platform Specialty Products, the company backed by activist investor Bill Ackman, has agreed to buy Arysta LifeScience in a deal valuing the Irish agriculture chemical maker at $3.51bn, including debt....
...device maker received an unfavourable ruling from a federal court in Delaware banning it from selling its aortic heart valve replacement system, which was earlier found to infringe a patent by rival Edwards Lifesciences...
...Stuart’s early career began at Oracle and he has worked on major data and information initiatives for companies including United Healthcare Group, Edwards Lifesciences and most recently Spectrum Pharmaceuticals...
...- The perplexing contradiction of the genus Capsicum. (h/t The Browser) - Further, further reading....
...Genus, however, said it had set the payment date for April 8 “to avoid the Easter holidays”....
...capacities including, variously, chairman, chief executive, committee chair, senior adviser and board member of pharmaceutical, life sciences and investment companies such as GlaxoSmithKline, Allergan Inc...
...Edwards Lifesciences tumbled 21.2 per cent to $84.6, making it the worst-hit stock on the S&P 500, after the cardiovascular equipment maker warned that third-quarter revenues would be lower than expected...
...Edwards Lifesciences tumbled 14 per cent to $92.30 in after-market trading as the maker of cardiovascular equipment said sales for the third quarter would fall short of market expectations....
...Permira’s last deal, the Y100bn acquisition of Tokyo-based Arysta LifeScience in October 2007, was another secondary buyout, from a Hong Kong-based investment group....
...: Live blog: Putin’s inauguration, Moscow Times Will market pressure force India Inc to make things beautiful, Economic Times The rich boy syndrome – Abuja/Lagos/London/Geneva, News Day (Nigeria) Glee at...
...Genus is a market leader and good pharmaceutical companies should be finding themselves in a demographic sweet spot. But one bothers me. It is Imperial Tobacco....
...And how many might have picked Genus, a supplier of bull semen and breeding pigs, which ranks at number four in SocGen’s consistency list?...
...Edwards Lifesciences climbed 5.1 per cent to $67.85, on the back of upgrades from several analysts. A Morgan Keegan noted pointed to the group’s strong product pipeline and prospects in China....
...Liberum said that “£3.8bn is the gross profit opportunity outlined by Genus’s new chief executive in the dairy, pork and beef genetics industry – nearly 20 times Genus’s current gross profit....
...However, the photo you chose to illustrate the article seems inappropriate to me – the crab pictured is commonly known as a Fiddler crab, most likely genus Uca, which inhabits sandy or marshy habitats....
...Siemens has 4 per cent, but the most interesting investor is Edwards Lifesciences, world market leader in heart valves, which is quoted on the New York Stock Exchange with a market capitalisation of $8bn...
...Edwards LifeSciences tumbled after the administrator of the government’s Medicare and Medicaid programmes dealt a blow to hopes of a rapid roll-out for its new cardiovascular device....
International Edition